Developmental Studies Hybridoma Bank

The Developmental Studies Hybridoma Bank (DSHB) is a biological-research resource established by the U.S. National Institutes of Health in 1986 to preserve, produce, and distribute hybridomas and the monoclonal antibodies generated from them. Rather than operating as a conventional commercial biotechnology company, the DSHB functions as a repository and distribution service for the research community. Its collection supports work in developmental biology, cell biology, molecular biology, neuroscience, muscle biology, cancer research, microbiology, and related fields. The bank is housed in the Department of Biology at the University of Iowa. It was initially established at Johns Hopkins University and transferred to Iowa in 1996, when David R. Soll assumed its directorship. The collection has grown to more than 5,000 hybridomas, supplied by individual investigators and organizations. Contributors have included the Muscular Dystrophy Association, the National Cancer Institute, the NIH Common Fund, and the European Molecular Biology Laboratory. The repository also accepts new deposits from scientists and institutions, allowing valuable antibody-producing cell lines to remain available beyond the original laboratory that created them. The DSHB's principal offering is access to research-use hybridomas and the monoclonal antibodies they produce. Its catalog is organized around scientific applications and biological targets, including cardiac and skeletal muscle, cell adhesion, cytoskeletal proteins, disease biomarkers, enzymes, extracellular matrix components, receptors, organelle markers, transcription factors, secreted proteins, microbes, and regulators of RNA and DNA. It also includes specialized collections such as CD markers, epitope tags, neurodevelopmental reagents, protein binders from the Affinomics program, muscular-dystrophy-associated antibodies, and cancer-target reagents developed through NIH programs. The bank operates on a cost-recovery basis. Research users agree that materials will be used for research rather than commercial purposes and will not be commercialized or passed to third parties. Users are also expected to acknowledge the DSHB and the contributing investigator or institution in publications and to provide publication citations to the repository. Depositors retain ownership of intellectual property associated with their hybridomas; placing a cell line in the bank does not prevent the depositor from pursuing separate commercial licensing. The DSHB covers the costs of maintaining, improving, producing, and distributing materials in its collection and has been self-funded since 1997, according to the cited reference material. The repository's scientific importance is linked to the breadth and provenance of its collection. Depositors have included prominent investigators in developmental biology, genetics, immunology, neuroscience, cell adhesion, muscle research, and cancer biology. Examples cited in reference material include antibodies associated with c-MYC and MyoD research, as well as deposits from laboratories led by Nobel laureates and members of the U.S. National Academy of Sciences. By making such reagents available to researchers worldwide, the DSHB helps preserve experimental resources, improve reproducibility, and reduce duplication of effort across laboratories.

The Developmental Studies Hybridoma Bank was created by the National Institutes of Health in 1986 as a national resource for preserving and distributing hybridomas and the monoclonal antibodies produced by those cell lines. Its purpose was to make specialized research reagents available to the wider basic-science community instead of leaving them confined to the laboratories that developed them. The bank's model combined biological preservation with distribution: investigators could deposit hybridomas, while other researchers could obtain antibody-producing materials for approved research use. The DSHB was initially operated at Johns Hopkins University. In 1996, it moved to the University of Iowa and came under the directorship of David R. Soll. The transfer placed the repository within the university's Department of Biology, where it continues to operate as an academic research resource. Since the move, the bank has expanded its collection through deposits from individual scientists, universities, research associations, and public research programs. Its holdings include materials connected with developmental biology, muscle research, cell adhesion, cytoskeletal organization, disease markers, receptors, enzymes, extracellular-matrix proteins, transcription factors, and many other areas. Collections have also been assembled around initiatives and contributing organizations, including the Muscular Dystrophy Association, the NIH Common Fund, the National Cancer Institute, and the European Molecular Biology Laboratory. The resulting catalog includes more than 5,000 hybridomas, according to the cited reference material. The DSHB's access framework is designed to support noncommercial scientific research. New users accept terms limiting use to research and prohibiting unauthorized commercialization or redistribution. Publications based on DSHB materials are expected to acknowledge both the repository and the original contributing investigator or institution, with citations supplied back to the bank. Depositors retain intellectual-property rights in their contributions, and the act of depositing does not prevent separate commercial licensing by the rights holder. A significant operational transition occurred in 1997, when the DSHB became self-funded and ceased relying on outside funding for its ongoing operations, as described in the reference material. Its cost-based model supports the expenses of maintaining hybridomas, producing antibodies, improving the collection, and distributing materials. This distinguishes the DSHB from an ordinary antibody vendor: its role is to maintain a shared scientific infrastructure and preserve reagents whose continued availability benefits many laboratories. The bank's contributor base includes internationally recognized scientists in genetics, developmental biology, neuroscience, immunology, muscle biology, and cancer research. Notable deposited materials include the anti-c-MYC hybridoma 9E10 associated with J. Michael Bishop and the MyoD clone D7F2 associated with Sir John Gurdon. Other deposits have come from laboratories led by prominent investigators such as Eric F. Wieschaus, Thomas Jessell, Corey Goodman, Gerald Rubin, and Helen Blau. Through these deposits and its worldwide distribution service, the DSHB has become an important infrastructure provider for experimental biology.

• 1997

  Became self-funded

  [1]Developmental Studies Hybridoma Banken.wikipedia.org

  The DSHB began operating on a self-funded basis for the maintenance, production, improvement, and distribution of collection materials.

• 1996

  Transferred to the University of Iowa

  [1]Developmental Studies Hybridoma Banken.wikipedia.org

  The repository moved from Johns Hopkins University to the University of Iowa and was placed under the directorship of David R. Soll.

• 1986

  Established as an NIH national resource

  [1]Developmental Studies Hybridoma Banken.wikipedia.org

  The National Institutes of Health created the DSHB to bank and distribute hybridomas and their monoclonal antibodies to the basic-science community.

• Expanded into a broad multidisciplinary collection

  [1]Developmental Studies Hybridoma Banken.wikipedia.org

  The bank assembled more than 5,000 hybridomas and broadened its holdings through contributions from universities, research organizations, and NIH-linked programs.

A nonprofit-oriented, research-use-only antibody and hybridoma repository that emphasizes long-term preservation, broad scientific access, contributor attribution, and cost-based distribution rather than commercial product sales.

• Research biological materials · 1986

  Hybridoma cell lines

  The DSHB preserves and distributes hybridomas, which are antibody-producing cell lines used by researchers to generate monoclonal antibodies. Deposited lines originate from laboratories and institutions working across developmental biology, cell biology, muscle research, neuroscience, cancer biology, and other disciplines. Access is intended for approved research use, with restrictions on commercialization and third-party redistribution.

• Research reagents · 1986

  Monoclonal antibodies

  The bank supplies monoclonal antibodies produced by its hybridoma collection. These reagents are used to detect, characterize, or study proteins, cell structures, developmental markers, receptors, enzymes, extracellular-matrix components, disease biomarkers, and other biological targets. The repository distributes them at cost and asks researchers to credit both the DSHB and the original contributor.

• Curated research collections

  Specialized antibody collections

  The catalog is organized into subject-focused collections covering cardiac and skeletal muscle, CD markers, cell adhesion, cytoskeleton, disease biomarkers, microbes, neurodevelopment, receptors, organelle-specific markers, RNA and DNA regulation, secreted proteins, transcription factors, and epitope tags. Additional collections are associated with the Muscular Dystrophy Association, EMBL Affinomics, the NIH Common Fund, and the NIH National Cancer Institute's CPTAC program.

• 1997

  Adoption of a self-funded operating modelStrategy

  Background

  The repository needed a sustainable way to cover the costs of maintaining, producing, improving, and distributing its biological materials.

  Action taken

  The DSHB began relying on self-funding and cost-based distribution rather than outside funding for its continuing operations.

  Aftermath

  The bank continued operating as a research-resource repository while preserving access for the scientific community.

  Source

• 1996

  Relocation to the University of IowaStrategy

  Background

  The NIH-created resource had previously been housed at Johns Hopkins University and required a new institutional home.

  Action taken

  The DSHB was transferred to the University of Iowa, where it was placed in the Department of Biology under David R. Soll.

  Aftermath

  The University of Iowa became the repository's continuing academic base and operating location.

  Source

1. 1Developmental Studies Hybridoma Banken.wikipedia.org
2. 2Developmental Studies Hybridoma Bank official websitedshb.biology.uiowa.edu